MYGN Latest News, Press Relases and Analysis

All

Press Releases

24 days ago - By: Benzinga

Exploring Myriad Genetics's Earnings Expectations

7 days ago - By: Zacks Investment Research - Mentions: DGX TEM

How Did Tempus AI Power Its Move to Positive EBITDA in Q3?

13 days ago - By: Myriad Genetics, Inc.

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

13 days ago - By: Myriad Genetics, Inc.

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

14 days ago - By: Myriad Genetics, Inc.

Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs

14 days ago - By: Myriad Genetics, Inc.

Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs

18 days ago - By: Myriad Genetics, Inc.

Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference

20 days ago - By: Benzinga - Mentions: SRPT EVOK TCMD ARTL ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

21 days ago - By: Zacks Investment Research

Myriad (MYGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

21 days ago - By: Zacks Investment Research - Mentions: IBRX

Myriad Genetics (MYGN) Reports Break-Even Earnings for Q3

21 days ago - By: Myriad Genetics, Inc.

Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

21 days ago - By: Myriad Genetics, Inc. - Mentions: SOPH

Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

24 days ago - By: Myriad Genetics, Inc.

New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner

24 days ago - By: Myriad Genetics, Inc.

New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner

a month ago - By: Myriad Genetics, Inc.

Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025

a month ago - By: Myriad Genetics, Inc.

Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025

a month ago - By: Myriad Genetics, Inc.

Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel

a month ago - By: Myriad Genetics, Inc.

Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel

2 months ago - By: D S Simon

Breast Cancer Awareness Month: Patient and Clinician Share Insights on how to tackle the fear of cancer screenings on YourUpdateTV

2 months ago - By: Zacks Investment Research - Mentions: ILMN TMO QGEN

MYRIAD GENETICS INC (MYGN) Stock News

MYGN Latest News, Press Relases and Analysis

Exploring Myriad Genetics's Earnings Expectations

How Did Tempus AI Power Its Move to Positive EBITDA in Q3?

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs

Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs

Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference

12 Health Care Stocks Moving In Tuesday's Intraday Session

Myriad (MYGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Myriad Genetics (MYGN) Reports Break-Even Earnings for Q3

Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner

New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner

Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025

Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025

Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel

Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel

Breast Cancer Awareness Month: Patient and Clinician Share Insights on how to tackle the fear of cancer screenings on YourUpdateTV

Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker